euroecho2010 dilated cardiomyopathy diagnosis moya 550

Upload: andi-suchy-qumala-sarie

Post on 14-Oct-2015

26 views

Category:

Documents


0 download

DESCRIPTION

Euroecho2010 Dilated Cardiomyopathy Diagnosis Moya 550

TRANSCRIPT

  • DILATED CADIOMYOPATHY AND DILATED CADIOMYOPATHY AND

    JL Moya JL Moya MurMur

    DIFFERENCIAL DIAGNOSIS DIFFERENCIAL DIAGNOSIS

    Hospital Ramn y CajalHospital Ramn y CajalMadrid. Madrid. SpainSpain

    I do not have any conflict of interest

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • Classification of the Classification of the cardiomyopathiescardiomyopathies: a position statement from the : a position statement from the European Society of Cardiology Working Group on Myocardial and European Society of Cardiology Working Group on Myocardial and DericardialDericardial DiseasesDiseases. 2008. 2008

    Familial Non Familial

    DCM

    Evidence of LV dilationImpaired LV contraction.

    Coronary artery diseaseCoronary artery diseaseHypertensionValvular heart disease

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • INITIAL EVALUATION AND DIAGNOSIS

    PROGNOSTIC EVALUATION

    GUIDING AND MONITORING TREATMENTGUIDING AND MONITORING TREATMENT

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • Analysis of morphology and systolic functionAnalysis of morphology and systolic function

    LV spherical dilationLV spherical dilationNormal or reduced wall thicknessNormal or reduced wall thicknessPoor wall thickeningPoor wall thickeningPoor wall thickeningPoor wall thickeningDyssynchronyDyssynchrony movementmovementAbnormal systolic parametersAbnormal systolic parametersFour chambers enlargementFour chambers enlargementFour chambers enlargementFour chambers enlargement

    LVEDV > 112%; EF < 45%LVEDV > 112%; EF < 45%

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • Analysis of morphology and systolic function

    Mitral Annulus Peak Systolic Mitral Annulus Peak Systolic VelocityVelocity

    Mitral Annulus Peak Systolic Mitral Annulus Peak Systolic DisplacementDisplacement

    SphericitySphericity indexindexmyocardial performance index myocardial performance index

    dPdTdPdTPeak Systolic StrainPeak Systolic Strain

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • Analysis of diastolic function and filling pressure.Analysis of diastolic function and filling pressure.

    TDI PVF LA vol.TDI PVF LA vol.Mitral filling patternMitral filling pattern

    Recommendations for the evaluation of left ventricularevaluation of left ventricular diastolic function by echocardiography.

    Nagueh SF Eur J EchocardiogrNagueh SF. Eur J Echocardiogr. 2009 Mar;10(2):165-93.

    EUROECHO CONGRESS -COPENHAGEN - TEACHING

    COURSE 2010

  • Analysis of diastolic function and filling pressureAnalysis of diastolic function and filling pressure

    Dokainish H, Circulation. 2004 109(20) 2432 92004;109(20):2432-9.

    EUROECHO CONGRESS -COPENHAGEN - TEACHING

    COURSE 2010

  • Analysis of Analysis of valvularvalvular function: mitral regurgitationfunction: mitral regurgitationLV remodelingLV remodeling

    posterior papillary Muscle displacement

    Tethering of theMitral leaflet

    excess of

    III b , Carpentier valvular Tenting

    Annulus dilation

    Dyssynchrony

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • TentingTentingLV remodelingLV remodelinggg

    PPMPPM despdesp

    EROERO

    PPM PPM despdesp

    YiYi Ci l tiCi l ti

    PPM PPM despdesp

    YiuYiu. . CirculationCirculation. . 2000;102:14002000;102:1400--1406 1406

    tentingtentingT tiT tiTentingTenting

    M.R. M.R. severityseverity

    SadeghpourSadeghpour J J CardiothoracCardiothorac SurgSurg. . 2008; 3: 54 2008; 3: 54

  • Analysis of pulmonary pressure and right Analysis of pulmonary pressure and right ventricular functionventricular function

    PSPCATE

    DOPPLER

    Kaul S, JM. Am Heart J 1984;107:526531.

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • IDIOPHATIC HCM

    SARCOIDOSIS CHAGASAMYLOIDOSISAMYLOIDOSIS

    Thomas DE. European Journal of Echocardiography (2009) 10, iii15iii21

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • Left ventricular nonLeft ventricular non--compactioncompaction

    Family screening200 patients with cardiac failure

    anticoagulation,

    protective device

    24% satisfy one criteria

    5 /60 (8%) control subjects protective device therapy

    5 /60 (8%) control subjects satisfy some criteria.

    Kohli. Eur Heart J 2008; 29:8995

  • INITIAL EVALUATION AND DIAGNOSIS

    PROGNOSTIC EVALUATION

    GUIDING AND MONITORING TREATMENTGUIDING AND MONITORING TREATMENT

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • E F

    Systolic function Systolic function

    TDIE.F. TDI

    Mitral annulus systolic velocity(TDI)(TDI)

    SERRAY JACC 1986;7:729Wang JACC 2003, 41: 820-826

  • SphericitySphericity indexindex DyssynchronyDyssynchrony

    L

    D

    S h i it i d L / DSphericity index = L / D

    Cho GY JACC 2005;46:2237 43Tischler. JACC. 1993;22,3, 751-757

    Cho GY,. JACC 2005;46:2237 43.

  • DIASTOLIC MITRAL FILLING

    Diastolic function Diastolic function DIASTOLIC MITRAL FILLING

    Mller JACC, 2000; 36:1841-1846Alameda M , Moya, JL Rev Esp Cardiol 2002;55(4):372-82

    Campolla. JACC 38,, 2001, 1675-1684Alberto Garca-Lled, Jos L. Moya, Rev Esp Cardiol. 2005;58(9):1029-36

  • Hillis GS, J Am Coll Cardiol 2004;43:360 7.Beinart J Am Coll Cardiol, 2004; 44:327-334,Mller Circulation. 2003;107:2207

    The prognostic capacity of echo increases asSystolic function , Diastolic function Filling pressures are introduced in the model

    LAV increment the prognostic information of Clinical , systolic and diastolic function

    Filling pressures, are introduced in the model

  • Mitral regurgitation. Mitral regurgitation. Ischaemic dilated cardiomyopathy

    Asynptomatics.Ischaemic dilated cardiomyopathy

    Grigioni et al. Circulation 2001; 103:1759-64 Grigioni et al. JACC 2005,45(2)260-7.

    i h i dil t d di thTenting area is an independent predictor of mortality and hospitalizations in patients with NICMP and FMR.

    non-ischaemic dilated cardiomyopathy

    Karaca O, Eur J Heart Fail. 2010 Nov 23.

  • Right ventricular function and pulmonary pressureRight ventricular function and pulmonary pressure

    Vel de IT < 2,5 m/sg

    Vel de IT > 2,5 m/sg

    Stefano Ghio. MD Am J Cardiol. 2000 Apr 1;85(7):837-42.

    Abramson Ann Int Med 92:116:888

  • INITIAL EVALUATION AND DIAGNOSIS

    PROGNOSTIC EVALUATION

    GUIDING AND MONITORING TREATMENTGUIDING AND MONITORING TREATMENT

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • Medical Therapypy

    Mitral repairMitral repair

    Anticoagulation Therapy

    Resynchronization Therapy

    ICD Therapy

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • F C IIIF C III--IVIVF.C. IIIF.C. III IVIVEF < 35% EF < 35%

    QRS > 120msQRS > 120msQRS > 120msQRS > 120ms

    ?%?%NO THERAPYNO THERAPY

    2020--30% 30% RST THERAPYRST THERAPY

    NO RESPONSE NO RESPONSE NO RESPONSENO RESPONSE

    ECHOCARDIOGRAPHY

  • SeptSept.

    L. Wall

    BaxBax JJ, Am J JJ, Am J CardiolCardiol 2003; 92:12382003; 92:1238

    SLWD 60SLWD > 60 ms

    > 140 ms

    SPWMD > 130 ms LVFT < 40%

    > 140 ms

  • PROSPECTPROSPECT

    No single mechanical echocardiographic measure of dyssynchrony may be recommended to improve patient selection for resynchronization therapy.

    Method to determine the mechanical dyssynchrony needs further development.

    Chung Circulation 2008; 117:2608

  • 1 2

    3 4

    WE NEED A METHODWE NEED A METHOD

    --DetectDetect dyssynchronydyssynchrony and respondersand respondersDetect Detect dyssynchronydyssynchrony and respondersand responders--Low variabilityLow variability--Better results than obtained with QRS durationBetter results than obtained with QRS duration--With results confirmed in prospective studiesWith results confirmed in prospective studiesp pp p

  • 2010 F d U d t f ESC G id liG id li2010 Focused Update of ESC Guidelines Guidelines on device therapy in heart failure. on device therapy in heart failure. European Heart Journal (2010) 31, 26772687

    EUROECHO CONGRESS - COPENHAGEN -TEACHING COURSE 2010

  • For Simpsons rule, Bland-Altman limits of agreement p , g(95% CI) ranged from LVEF 7% to 25% (median 18%);

  • Why do no respond?Why do no respond?

    Improper patient selection Improper patient selection.

    No mechanical asynchrony.

    Improper position the electrodeImproper position the electrode.

    Advanced state of cardiomyopathy

    /incorrect AV/VV delay optimization

    Dysfunction device,

    displacement of the cable.

    Arrhythmias, spontaneous or mediated by the PM

  • How to optimize dyssynchrony with echo?

    1.- program different AV or VV delays

    septal2.- analyze their repercussion in:

    -SYNCHRONYLat. Wall

    SYNCHRONY-SYSTOLIC FUNCTION: AORTIC VTI-DIASTOLIC FUNCTION: MITRAL FILLING.

  • RV20LV LV20RV LV40RVLV00RVbasal

    TDI vel

    TTTT

    Strain

  • Kedia. Am J Cardiol 2006;98:780 785

    Boriani Am Heart J 2006;151:1050-8. (RHYTHM II )

    Vidal B, Am J Cardiol 2007;15:1002

  • ASE EXPERT CONSENSUS STATMENT

    Current studies have shown thas subsets of patients do acutely benefit from p yV-V optimization, but long term benefit has yet to be determined

    GorcsanGorcsan III JASE 2008;21: marzo: 191III JASE 2008;21: marzo: 191--245245

  • Echocardiography is essential in patients with SD and DCM:

    -Describe the typical features and associated findings of patientswith Dilated Cardiomyopathy.

    -Assess systolic and diastolic function, mitral regurgitation, and RV function.

    - Identify echo marker of adverse prognosis

    - is useful in guiding and monitoring therapeutic management.